A world-class manufacturing space, our Sanford site is home to one of the largest U.S. biotechnology hubs. With a legacy of monoclonal antibodies (mAbs) innovation spanning over three decades, we're dedicated to unlocking the bio-logic brilliance of your therapy.
Sanford has flexible, multi-product manufacturing with a focus on vaccines, intermediates, drug substance, and gene therapy drug substance and drug product. We offer full-scope vaccine manufacturing and end-to-end gene therapy capabilities, including drug product formulation and filling.
With expertise in both adherent and suspension cell culture processes, we deliver industry-leading yield and productivity, helping you bring your antibody therapeutic to patients at speed.
Sanford, a Carolina STAR site since 2007, is experienced in tech transfer, optimization, and commercialization to deliver breakthrough medicines globally.
Accelerate your biologics journey with Sanford's 35+ years of expertise in cell culture processes. Our dedicated team, combined with Pfizer's global network and resources, provides the support you need to achieve success.
